Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.265 USD | -0.22% | -5.17% | -88.80% |
May. 16 | Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating | MT |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.80% | 67.71M | |
+32.88% | 50.85B | |
+0.13% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.24% | 26.11B | |
-21.74% | 19.13B | |
+8.48% | 13.05B | |
+27.85% | 12.16B | |
+24.57% | 12.08B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- Oppenheimer Initiates Coverage on AN2 Therapeutics With Outperform Rating, $22 Price Target